This site is intended for healthcare professionals only
LoginRegister
NPPA Warns Drugmakers Against Arbitrary Pricing, Calls for MRP UniformityNPPA Revises Ceiling Prices for 6 Drugs Including Clarithromycin, Vitamin C, Details
Lupin Gets Expert Committee Nod To Conduct Phase I Trial of Certolizumab Pegol, IGRA TB Test Made MandatoryLupin's generic drug to treat ADHD symptoms gets USFDA approval
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancerMerck's Injectable Keytruda Proves Effective in Trial, Promises Easier Cancer Treatment
Unichem Labs Roha facility gets 3 USFDA observationsUSFDA Inspection: Dr Reddy's gets Form 483 with 7 observations for Bollaram facility
Novo Nordisk Launches Wegovy in South Africa, Ramping Up Obesity Drug Battle with Eli LillyNovo Nordisk Enters China's Obesity Market with Wegovy Launch, Eyes 180 Million Patients
Eli Lilly Gets CDSCO Panel Nod for Ixekizumab Safety Label UpdateEli Lilly's Experimental Drug Muvalaplin Lowers Inherited Cholesterol by Up to 86 percent
Lupin, Avas launch myotonia treatment NaMuscla in ItalyLupin launches generic equivalent of Bumex Injection in US
Pharm D Graduates Now Eligible for Drug Inspector Recruitment, Says MPSCTN Health to close registration, choice filling for Pharm D Counselling Tomorrow, check seat matrix
USFDA approves AbbVie giant cell arteritis drug Rinvoq in adultsAbbVie gets European Commission nod for Elahere for Platinum-Resistant ovarian cancer
Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in bloodIndian Pharma Market grows at 6.8 percent in October, Chronic Therapies Dominate: IQVIA
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancerMerck gets positive EU CHMP opinion for Keytruda plus Chemotherapy as first-line treatment for adult...
Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy licenseRatio enters license, collaboration agreement with Novartis for SSTR2-targeting Radiotherapeutic...
X